Clinical Trials Directory

Trials / Terminated

TerminatedNCT00298805

A Quality of Life Study in Patients With Migraines

Dysphoric-like Disorder of Epilepsy, Is It Unique?

Status
Terminated
Phase
Study type
Observational
Enrollment
52 (actual)
Sponsor
Northwell Health · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare depressive characteristics in migraine patients to those observed in patients with epilepsy in a previous study, and determine whether those symptoms are unique to patients with epilepsy.

Detailed description

A form of depression known as dysphoric-like disorder is common in people with epilepsy, which may significantly affect the quality of life in these people, as shown in a previous study. However, it is unclear if this depressive disorder is unique to patients with epilepsy. In order to assess whether these symptoms are unique and idiosyncratic to the epilepsy population, in this multi-center study, these dysphoric depressive features will be contrasted to those seen in patients with other neurologic or psychiatric conditions. Migraine is selected as one of the comparison disorders because it shares with epilepsy characteristics of being a recurrent episodic central nervous system disorder, and our site will only enroll patients with migraine headaches.

Conditions

Timeline

Start date
2006-01-01
Primary completion
2009-06-01
Completion
2013-04-01
First posted
2006-03-03
Last updated
2013-08-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00298805. Inclusion in this directory is not an endorsement.